Citigroup’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $167M | Buy |
|
|||||
2025
Q1 | $179M | Buy |
|
|||||
2024
Q4 | $137M | Sell |
|
|||||
2024
Q3 | $148M | Buy |
|
|||||
2024
Q2 | $118M | Sell |
|
|||||
2024
Q1 | $172M | Sell |
|
|||||
2023
Q4 | $178M | Sell |
|
|||||
2023
Q3 | $214M | Sell |
|
|||||
2023
Q2 | $244M | Sell |
|
|||||
2023
Q1 | $340M | Sell |
|
|||||
2022
Q4 | $462M | Buy |
|
|||||
2022
Q3 | $406M | Buy |
|
|||||
2022
Q2 | $371M | Sell |
|
|||||
2022
Q1 | $361M | Sell |
|
|||||
2021
Q4 | $404M | Buy |
|
|||||
2021
Q3 | $222M | Sell |
|
|||||
2021
Q2 | $258M | Sell |
|
|||||
2021
Q1 | $257M | Sell |
|
|||||
2020
Q4 | $257M | Buy |
|
|||||
2020
Q3 | $209M | Buy |
|
|||||
2020
Q2 | $182M | Buy |
|
|||||
2020
Q1 | $162M | Sell |
|
|||||
2019
Q4 | $222M | Sell |
|
|||||
2019
Q3 | $305M | Buy |
|
|||||
2019
Q2 | $105M | Sell |
|
|||||
2019
Q1 | $226M | Buy |
|
|||||
2018
Q4 | $122M | Buy |
|
|||||
2018
Q3 | $130M | Buy |
|
|||||
2018
Q2 | $105M | Sell |
|
|||||
2018
Q1 | $124M | Buy |
|
|||||
2017
Q4 | $117M | Sell |
|
|||||
2017
Q3 | $123M | Buy |
|
|||||
2017
Q2 | $96.7M | Sell |
|
|||||
2017
Q1 | $97.8M | Sell |
|
|||||
2016
Q4 | $117M | Buy |
|
|||||
2016
Q3 | $63.6M | Buy |
|
|||||
2016
Q2 | $81.2M | Sell |
|
|||||
2016
Q1 | $73M | Buy |
|
|||||
2015
Q4 | $69.7M | Sell |
|
|||||
2015
Q3 | $85M | Sell |
|
|||||
2015
Q2 | $116M | Buy |
|
|||||
2015
Q1 | $78.7M | Sell |
|
|||||
2014
Q4 | $124M | Buy |
|
|||||
2014
Q3 | $82.6M | Sell |
|
|||||
2014
Q2 | $102M | Buy |
|
|||||
2014
Q1 | $74M | Sell |
|
|||||
2013
Q4 | $248M | Buy |
|
|||||
2013
Q3 | $100M | Sell |
|
|||||
2013
Q2 | $97M | Buy |
|